Seres Therapeutics
World Rank (Jan-05-2024)
18,439
Market Cap (Jan-05-2024)
0.181 Billion USD
World Rank (Jul-30-2023)
11,584
Market Cap (Jul-30-2023)
0.600 Billion USD
World Rank (Dec-25-2022)
10,764
Market Cap (Dec-25-2022)
0.653 Billion USD
World Rank (Jan-07-2022)
10,779
Market Cap (Jan-07-2022)
0.79 Billion USD
Annual Revenue in USD
7 Million USD
Annual Net Income in USD
-250 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Seres Therapeutics is a Late Clinical Stage Biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome. The company annual revenue is 35 million USD and 145 employees as on 2020. The headquarters is in USA.
Company Website